# Microbiome Effect of Omadacycline on Healthy Volunteers

> **NCT06030219** · PHASE1 · COMPLETED · sponsor: **University of Houston** · enrollment: 32 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Omadacycline
- **DRUG:** Vancomycin Pill
- **DRUG:** Moxifloxacin

## Key facts

- **NCT ID:** NCT06030219
- **Lead sponsor:** University of Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-12
- **Primary completion:** 2023-09-01
- **Final completion:** 2023-09-01
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2025-03-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06030219

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06030219, "Microbiome Effect of Omadacycline on Healthy Volunteers". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06030219. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*